- Report
- November 2025
- 150 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- November 2025
- 150 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- July 2026
- 150 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Directory
- October 2026
Global
From €1793EUR$1,950USD£1,524GBP
- Newsletter
- October 2026
Global
€2753EUR$2,995USD£2,341GBP
- Report
- February 2026
- 130 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- December 2025
- 36 Pages
Global
From €2712EUR$2,950USD£2,306GBP
- Report
- November 2025
- 139 Pages
Global
From €4274EUR$4,650USD£3,634GBP
- Report
- November 2025
- 135 Pages
Global
From €4458EUR$4,850USD£3,790GBP
- Report
- October 2025
- 80 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- October 2025
- 89 Pages
Global
From €4137EUR$4,500USD£3,517GBP
- Report
- September 2026
Europe
From €4411EUR$4,799USD£3,751GBP
- Report
- April 2026
Africa, Middle East
From €4411EUR$4,799USD£3,751GBP
- Report
- October 2025
- 150 Pages
Middle East
From €5469EUR$5,950USD£4,650GBP
- Report
- June 2026
- 90 Pages
Asia Pacific
From €4366EUR$4,750USD£3,712GBP
- Report
- May 2026
- 102 Pages
Middle East
From €3631EUR$3,950USD£3,087GBP
- Report
- April 2026
North America
From €3171EUR$3,450USD£2,696GBP
- Report
- April 2026
Asia Pacific
From €3171EUR$3,450USD£2,696GBP
- Report
- April 2026
Europe
From €3171EUR$3,450USD£2,696GBP
- Report
- March 2026
Asia Pacific
From €3171EUR$3,450USD£2,696GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more